Literature DB >> 10761977

Role of heat shock proteins in the effect of NMDA and KCl on cerebellar granule cells survival.

S Alavez1, D Pedroza, J Morán.   

Abstract

Cerebellar granule cells (CGC) die apoptotically after five days in culture (DIV) at physiological concentrations of potassium (5 mM; K5). When CGC are depolarized (K25) or treated with NMDA (150 microM) cell survival is increased. CGC changed from K25 to K5 die after 24-48 h. It is known that heat shock protein (HSP) may protect from cell death. Here, we found that cells in K5 showed an increase in HSP-70 levels after 3 DIV. Similarly, in cells changed from K25 to K5, HSP-70 levels were increased after 6 h. Neither NMDA nor K25 treatment affected HSP-70 levels from 2-7 DIV. Ethanol or thermal stress induced HSP-70, but cell survival was not affected in K5 medium. These results suggest that HSP, particularly HSP-70, are not involved in the mechanisms by which NMDA and KCl promote cell survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761977     DOI: 10.1023/a:1007584802989

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

1.  Heat shock protects cultured neurons from glutamate toxicity.

Authors:  G Rordorf; W J Koroshetz; J V Bonventre
Journal:  Neuron       Date:  1991-12       Impact factor: 17.173

2.  Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis.

Authors:  C Galli; O Meucci; A Scorziello; T M Werge; P Calissano; G Schettini
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

3.  Stimulation of the N-methyl-D-aspartate receptor promotes the biochemical differentiation of cerebellar granule neurons and not astrocytes.

Authors:  J Moran; A J Patel
Journal:  Brain Res       Date:  1989-05-01       Impact factor: 3.252

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species.

Authors:  J B Schulz; M Weller; T Klockgether
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

6.  Caspase-3 expression by cerebellar granule neurons is regulated by calcium and cyclic AMP.

Authors:  J Moran; T Itoh; U R Reddy; M Chen; E S Alnemri; D Pleasure
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

7.  Effect of potassium depolarization on phosphate-activated glutaminase activity in primary cultures of cerebellar granule neurons and astroglial cells during development.

Authors:  J Moran; A J Patel
Journal:  Brain Res Dev Brain Res       Date:  1989-03-01

8.  Hyperthermia protects against light damage in the rat retina.

Authors:  M F Barbe; M Tytell; D J Gower; W J Welch
Journal:  Science       Date:  1988-09-30       Impact factor: 47.728

9.  The role of depolarization in the survival and differentiation of cerebellar granule cells in culture.

Authors:  V Gallo; A Kingsbury; R Balázs; O S Jørgensen
Journal:  J Neurosci       Date:  1987-07       Impact factor: 6.167

10.  Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat.

Authors:  M Chopp; H Chen; K L Ho; M O Dereski; E Brown; F W Hetzel; K M Welch
Journal:  Neurology       Date:  1989-10       Impact factor: 9.910

View more
  2 in total

1.  Influence of geranylgeranylacetone on the expression of HSP70 in retina of rats with chronic IOP elevation.

Authors:  Zhi-Li Liu; Ying-Rong Wang; Qian Sha; Qing-Zhu Nie
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

2.  Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model.

Authors:  Joseph Caprioli; Yoko Ishii; Jacky M K Kwong
Journal:  Trans Am Ophthalmol Soc       Date:  2003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.